BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36097175)

  • 1. A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma.
    Zaidi AH; Pratama MY; Omstead AN; Gorbonova A; Mansoor R; Melton-Kreft R; Jobe BA; Wagner PL; Kelly RJ; Goel A
    Br J Cancer; 2022 Nov; 127(11):2016-2024. PubMed ID: 36097175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
    Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.
    Cheung WY; Zhai R; Kulke MH; Heist RS; Asomaning K; Ma C; Wang Z; Su L; Lanuti M; Tanabe KK; Christiani DC; Liu G
    Carcinogenesis; 2009 Aug; 30(8):1363-7. PubMed ID: 19520791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
    Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
    Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
    Cheung WY; Zhai R; Bradbury P; Hopkins J; Kulke MH; Heist RS; Asomaning K; Ma C; Xu W; Wang Z; Hooshmand S; Su L; Christiani DC; Liu G
    Int J Cancer; 2012 Dec; 131(11):2478-86. PubMed ID: 22422400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
    Kim SM; Park YY; Park ES; Cho JY; Izzo JG; Zhang D; Kim SB; Lee JH; Bhutani MS; Swisher SG; Wu X; Coombes KR; Maru D; Wang KK; Buttar NS; Ajani JA; Lee JS
    PLoS One; 2010 Nov; 5(11):e15074. PubMed ID: 21152079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.
    Korbut E; Krukowska K; Magierowski M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma.
    Li Z; Yao Q; Zhao S; Wang Z; Li Y
    Artif Intell Med; 2017 Feb; 76():1-6. PubMed ID: 28363284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
    Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
    Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
    Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
    Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
    Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
    Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of autophagy-related genes in esophageal adenocarcinoma.
    Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
    BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
    Newell F; Patel K; Gartside M; Krause L; Brosda S; Aoude LG; Loffler KA; Bonazzi VF; Patch AM; Kazakoff SH; Holmes O; Xu Q; Wood S; Leonard C; Lampe G; Lord RV; Whiteman DC; Pearson JV; Nones K; Waddell N; Barbour AP
    BMC Med Genomics; 2019 Feb; 12(1):31. PubMed ID: 30717762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
    Bansal A; Gupta V; Wang K
    J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.
    Kuramochi H; Vallböhmer D; Uchida K; Schneider S; Hamoui N; Shimizu D; Chandrasoma PT; DeMeester TR; Danenberg KD; Danenberg PV; Peters JH
    J Gastrointest Surg; 2004 Dec; 8(8):1007-16; discussion 1016-7. PubMed ID: 15585388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.